Sustained release formulations comprising very low molecular weight polymers
US9724397B2 · kind B2 · utility
4Cited by
4References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2007 |
| Grant date | Aug 8, 2017 |
| Priority date | — |
| Expiry date | Aug 28, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a parenteral, sustained and controlled release, semisolid formulation comprising an end-capped oligomer and at least one active substance without any supplementary viscosity reducing agent or excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.